New hope for kidney cancer: triple-drug combo enters phase 2 trial
Disease control
Recruiting now
This study tests three different drug combinations in 120 people with advanced kidney cancer that has spread. The goal is to see which combination works best to shrink tumors. Participants will receive either a new two-drug or three-drug combination, or a standard two-drug therap…
Phase: PHASE2 • Sponsor: Brian Rini • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC